Objectives: To assess the ligand binding characteristics of insulin and insulin-like growth factor I receptors in normal and preeclamptic placentas.
Design And Methods: This study was done cross sectionally in trophoblast membranes obtained from 10 normotensive and 9 preeclamptic pregnant women. The affinity and number of binding sites of insulin and insulin-like growth factor I receptors were assessed by binding assays and Scatchard plot analysis.
Results: Placental and newborn birth weights were significantly (P < 0.001) lower in the preeclamptic group. The K(d) values of placental insulin receptors (IR) were significantly higher in the preeclamptic group than in the normotensive group (1.08 +/- 0.24 x 10(-9) vs. 0.81 +/- 0.13 x 10(-9) M, P < 0.01), without differences in the number of receptors. In contrast, no differences were observed in the affinity and the number of insulin-like growth factor I receptors (IGF-1R) between groups. Placental weight was associated negatively with the K(d) values of IR (P < 0.05) and positively with the number of placental IGF-1R (P < 0.05); while newborn birth weight was associated positively with the number of IGF-1R (P < 0.05). In addition, both systolic and diastolic blood pressure correlated significantly with K(d) values of placental IR (P < 0.01).
Conclusions: These data demonstrate that preeclampsia is associated with low placental IR affinity. In addition, this study suggests an association between the affinity of IR and number of IGF-1R with placental and/or fetal growth. Furthermore, high blood pressure may affect the affinity of placental IR, but not the affinity or number of placental IGF-1 receptors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.clinbiochem.2004.10.013 | DOI Listing |
Pak J Pharm Sci
January 2025
Department of Pathophysiology, Shanxi Medical University, Jinzhong, Shanxi Province, China.
This study investigates the prognostic value of serum biomarkers PD-L1 and IGFBP-2 in patients with esophageal carcinoma. It finds a significant positive correlation between these biomarkers and established tumor markers CEA and CYFRA21-1. The 3-year survival rate for the patient cohort was 45.
View Article and Find Full Text PDFPak J Pharm Sci
January 2025
Department of Pediatrics, Changxing Peoples' Hospital Pediatrics, Huzhou, Zhejiang Province, China.
Recombinant human growth hormone (rhGH) injections combined with Anastrozole are increasingly used to treat adolescent idiopathic short stature (ISS), warranting further research. This study evaluated their effects on height, growth rate and adverse reactions in 72 adolescents with ISS treated at our hospital from December 2021 to December 2022. Patients were divided into a control group (rhGH alone) and a study group (rhGH + Anastrozole).
View Article and Find Full Text PDFMol Cancer
January 2025
Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, 510630, P. R. China.
Eur Geriatr Med
January 2025
Department of Public Health, Jining Medical University, Jining, 272000, China.
Purpose: Sarcopenia is an age-related disease that is related to nutritional intake and chronic low-grade inflammation. The aim of this study was to investigate the association of dietary intake, inflammatory markers and sarcopenia among the community-dwelling older adults.
Methods: A total of 1001 older adults aged 60 and above were recruited.
J Cachexia Sarcopenia Muscle
February 2025
Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.
Background: A decline in skeletal muscle mass and function known as skeletal muscle sarcopenia is an inevitable consequence of aging. Sarcopenia is a major cause of decreased muscle strength, physical frailty and increased muscle fatigability, contributing significantly to an increased risk of physical disability and functional dependence among the elderly. There remains a significant need for a novel therapy that can improve sarcopenia and related problems in aging.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!